fanta.bio Sample: CNhs11263
15504 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1061 / 11910 (8.9%) | 319 / 119100 (0.3%) | −324.0 | −324.0 | 33.26 |
| HIF1A SRX11007095 | HK-2 Kidney | 2040 / 11910 (17.1%) | 711 / 119100 (0.6%) | −324.0 | −324.0 | 28.69 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1630 / 11910 (13.7%) | 585 / 119100 (0.5%) | −324.0 | −324.0 | 27.86 |
| SCML2 SRX644728 | 293 Kidney | 1417 / 11910 (11.9%) | 522 / 119100 (0.4%) | −324.0 | −324.0 | 27.15 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1540 / 11910 (12.9%) | 572 / 119100 (0.5%) | −324.0 | −324.0 | 26.92 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2255 / 11910 (18.9%) | 880 / 119100 (0.7%) | −324.0 | −324.0 | 25.63 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2192 / 11910 (18.4%) | 865 / 119100 (0.7%) | −324.0 | −324.0 | 25.34 |
| TP53 SRX19538279 | Osteoblasts Bone | 484 / 11910 (4.1%) | 201 / 119100 (0.2%) | −324.0 | −324.0 | 24.08 |
| FOXP1 SRX736067 | LNCAP Prostate | 1525 / 11910 (12.8%) | 886 / 119100 (0.7%) | −324.0 | −324.0 | 17.21 |
| MYH11 SRX265221 | ME-1 Blood | 753 / 11910 (6.3%) | 460 / 119100 (0.4%) | −324.0 | −324.0 | 16.37 |
| MED1 SRX9419945 | BT-474 Breast | 2691 / 11910 (22.6%) | 2237 / 119100 (1.9%) | −324.0 | −324.0 | 12.03 |
| MED1 SRX9419944 | BT-474 Breast | 2631 / 11910 (22.1%) | 2188 / 119100 (1.8%) | −324.0 | −324.0 | 12.02 |
| BRD4 SRX9419935 | BT-474 Breast | 2663 / 11910 (22.4%) | 2252 / 119100 (1.9%) | −324.0 | −324.0 | 11.82 |
| BRD4 SRX9419937 | BT-474 Breast | 2660 / 11910 (22.3%) | 2281 / 119100 (1.9%) | −324.0 | −324.0 | 11.66 |
| BRD4 SRX9419936 | BT-474 Breast | 2712 / 11910 (22.8%) | 2338 / 119100 (2.0%) | −324.0 | −324.0 | 11.60 |
| MED1 SRX9419946 | BT-474 Breast | 2728 / 11910 (22.9%) | 2359 / 119100 (2.0%) | −324.0 | −324.0 | 11.56 |
| MED1 SRX9419947 | BT-474 Breast | 2646 / 11910 (22.2%) | 2301 / 119100 (1.9%) | −324.0 | −324.0 | 11.50 |
| BRD4 SRX9419938 | BT-474 Breast | 2650 / 11910 (22.3%) | 2382 / 119100 (2.0%) | −324.0 | −324.0 | 11.13 |
| EZH2 SRX2146136 | LNCAP Prostate | 6353 / 11910 (53.3%) | 6146 / 119100 (5.2%) | −324.0 | −324.0 | 10.34 |
| BRD4 SRX736201 | 90-8TL Neural | 4961 / 11910 (41.7%) | 4902 / 119100 (4.1%) | −324.0 | −324.0 | 10.12 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1499 / 11910 (12.6%) | 1992 / 119100 (1.7%) | −324.0 | −324.0 | 7.53 |
| TP53 SRX19538274 | U2OS Bone | 409 / 11910 (3.4%) | 118 / 119100 (0.1%) | −313.1 | −309.9 | 34.66 |
| TP53 SRX19538268 | U2OS Bone | 406 / 11910 (3.4%) | 119 / 119100 (0.1%) | −309.7 | −306.5 | 34.12 |
| TP53 SRX19538276 | U2OS Bone | 402 / 11910 (3.4%) | 120 / 119100 (0.1%) | −305.3 | −302.2 | 33.50 |
| HIF1A SRX20663235 | HK-2 Kidney | 442 / 11910 (3.7%) | 203 / 119100 (0.2%) | −298.7 | −295.5 | 21.77 |
| TP53 SRX19538280 | Osteoblasts Bone | 385 / 11910 (3.2%) | 142 / 119100 (0.1%) | −277.1 | −274.0 | 27.11 |
| TP53 SRX19538281 | Osteoblasts Bone | 420 / 11910 (3.5%) | 210 / 119100 (0.2%) | −276.0 | −273.0 | 20.00 |
| TP53 SRX19538275 | U2OS Bone | 362 / 11910 (3.0%) | 117 / 119100 (0.1%) | −269.6 | −266.5 | 30.94 |
| TP53 SRX19538267 | U2OS Bone | 354 / 11910 (3.0%) | 108 / 119100 (0.1%) | −267.3 | −264.3 | 32.78 |
| TP53 SRX19538273 | U2OS Bone | 352 / 11910 (3.0%) | 110 / 119100 (0.1%) | −264.3 | −261.2 | 32.00 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 383 / 11910 (3.2%) | 165 / 119100 (0.1%) | −263.7 | −260.7 | 23.21 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 558 / 11910 (4.7%) | 644 / 119100 (0.5%) | −253.0 | −249.9 | 8.66 |
| TP53 SRX19538269 | U2OS Bone | 430 / 11910 (3.6%) | 328 / 119100 (0.3%) | −240.3 | −237.3 | 13.11 |
| BRD4 SRX736204 | 90-8TL Neural | 874 / 11910 (7.3%) | 2021 / 119100 (1.7%) | −233.2 | −230.2 | 4.32 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 998 / 11910 (8.4%) | 2665 / 119100 (2.2%) | −228.9 | −225.9 | 3.74 |
| AGO2 SRX4708039 | Hep G2 Liver | 1478 / 11910 (12.4%) | 5417 / 119100 (4.5%) | −224.6 | −221.7 | 2.73 |
| IRF3 SRX11453858 | Hep G2 Liver | 273 / 11910 (2.3%) | 62 / 119100 (0.1%) | −219.6 | −216.7 | 44.03 |
| TP53 SRX19538270 | U2OS Bone | 397 / 11910 (3.3%) | 333 / 119100 (0.3%) | −212.4 | −209.5 | 11.92 |
| AR SRX10820653 | LNCAP Prostate | 311 / 11910 (2.6%) | 144 / 119100 (0.1%) | −209.3 | −206.4 | 21.60 |
| TP53 SRX19538271 | U2OS Bone | 567 / 11910 (4.8%) | 900 / 119100 (0.8%) | −208.1 | −205.2 | 6.30 |
| TP53 SRX19538282 | Osteoblasts Bone | 345 / 11910 (2.9%) | 236 / 119100 (0.2%) | −201.8 | −198.9 | 14.62 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 487 / 11910 (4.1%) | 667 / 119100 (0.6%) | −198.0 | −195.1 | 7.30 |
| IRF3 SRX11453861 | Hep G2 Liver | 246 / 11910 (2.1%) | 61 / 119100 (0.1%) | −194.4 | −191.5 | 40.33 |
| PBX4 SRX2731658 | PC-3 Prostate | 753 / 11910 (6.3%) | 18457 / 119100 (15.5%) | −192.2 | −189.3 | 0.41 |
| AR SRX10820651 | LNCAP Prostate | 320 / 11910 (2.7%) | 221 / 119100 (0.2%) | −186.4 | −183.5 | 14.48 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 695 / 11910 (5.8%) | 1620 / 119100 (1.4%) | −183.0 | −180.1 | 4.29 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 479 / 11910 (4.0%) | 737 / 119100 (0.6%) | −179.6 | −176.7 | 6.50 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 927 / 11910 (7.8%) | 2924 / 119100 (2.5%) | −172.0 | −169.2 | 3.17 |
| Epitope tags SRX10549776 | K-562 Blood | 1069 / 11910 (9.0%) | 3787 / 119100 (3.2%) | −168.4 | −165.5 | 2.82 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1059 / 11910 (8.9%) | 3753 / 119100 (3.2%) | −166.6 | −163.8 | 2.82 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 229 / 11910 (1.9%) | 91 / 119100 (0.1%) | −161.4 | −158.6 | 25.16 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 509 / 11910 (4.3%) | 981 / 119100 (0.8%) | −159.6 | −156.8 | 5.19 |
| YAP1 SRX757325 | H2052 Lung | 548 / 11910 (4.6%) | 14301 / 119100 (12.0%) | −159.4 | −156.6 | 0.38 |
| BMI1 SRX644729 | 293 Kidney | 226 / 11910 (1.9%) | 101 / 119100 (0.1%) | −153.8 | −151.0 | 22.38 |
| FOXA1 SRX176863 | MCF-7 Breast | 245 / 11910 (2.1%) | 9244 / 119100 (7.8%) | −152.9 | −150.1 | 0.27 |
| AGO2 SRX6783958 | Hep G2 Liver | 940 / 11910 (7.9%) | 3255 / 119100 (2.7%) | −152.5 | −149.8 | 2.89 |
| FOXA1 SRX4815198 | MCF-7 Breast | 751 / 11910 (6.3%) | 16973 / 119100 (14.3%) | −152.5 | −149.7 | 0.44 |
| FOS SRX150477 | MCF 10A Breast | 534 / 11910 (4.5%) | 13814 / 119100 (11.6%) | −151.4 | −148.7 | 0.39 |
| KAT6A SRX20971022 | Fibroblasts Others | 200 / 11910 (1.7%) | 67 / 119100 (0.1%) | −147.6 | −144.8 | 29.85 |
| FOXA1 SRX176862 | MCF-7 Breast | 282 / 11910 (2.4%) | 9709 / 119100 (8.2%) | −147.5 | −144.8 | 0.29 |
| FOS SRX150478 | MCF 10A Breast | 569 / 11910 (4.8%) | 14174 / 119100 (11.9%) | −147.2 | −144.4 | 0.40 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 498 / 11910 (4.2%) | 1029 / 119100 (0.9%) | −146.7 | −144.0 | 4.84 |
| TP53 SRX19538272 | U2OS Bone | 456 / 11910 (3.8%) | 854 / 119100 (0.7%) | −146.4 | −143.7 | 5.34 |
| YAP1 SRX757326 | H2052 Lung | 491 / 11910 (4.1%) | 12818 / 119100 (10.8%) | −141.5 | −138.8 | 0.38 |
| BRPF3 SRX796084 | RKO Digestive tract | 1102 / 11910 (9.3%) | 4418 / 119100 (3.7%) | −141.3 | −138.6 | 2.49 |
| BRD1 SRX286203 | RKO Digestive tract | 874 / 11910 (7.3%) | 3041 / 119100 (2.6%) | −140.5 | −137.8 | 2.87 |
| KAT7 SRX101303 | RKO Digestive tract | 986 / 11910 (8.3%) | 3728 / 119100 (3.1%) | −139.3 | −136.6 | 2.64 |
| FOXA1 SRX4815197 | MCF-7 Breast | 570 / 11910 (4.8%) | 13857 / 119100 (11.6%) | −138.1 | −135.4 | 0.41 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 516 / 11910 (4.3%) | 13055 / 119100 (11.0%) | −137.7 | −135.1 | 0.40 |
| AGO2 SRX6783957 | Hep G2 Liver | 914 / 11910 (7.7%) | 3328 / 119100 (2.8%) | −137.0 | −134.3 | 2.75 |
| BRPF3 SRX796085 | RKO Digestive tract | 789 / 11910 (6.6%) | 2613 / 119100 (2.2%) | −136.0 | −133.4 | 3.02 |
| STAT5B SRX831881 | CD8+ T cells Blood | 209 / 11910 (1.8%) | 108 / 119100 (0.1%) | −135.8 | −133.1 | 19.35 |
| FOXA1 SRX3931044 | MCF-7 Breast | 510 / 11910 (4.3%) | 12821 / 119100 (10.8%) | −133.8 | −131.1 | 0.40 |
| ESR1 SRX371469 | MCF-7 Breast | 236 / 11910 (2.0%) | 8466 / 119100 (7.1%) | −133.1 | −130.4 | 0.28 |
| ESR1 SRX7624157 | MCF-7 Breast | 610 / 11910 (5.1%) | 14230 / 119100 (11.9%) | −132.8 | −130.1 | 0.43 |
| BRPF3 SRX796086 | RKO Digestive tract | 1044 / 11910 (8.8%) | 4209 / 119100 (3.5%) | −132.0 | −129.4 | 2.48 |
| CDK9 SRX7366781 | MCF-7 Breast | 195 / 11910 (1.6%) | 92 / 119100 (0.1%) | −130.5 | −127.9 | 21.20 |
| NFYB SRX16608147 | HeLa Uterus | 216 / 11910 (1.8%) | 137 / 119100 (0.1%) | −130.2 | −127.6 | 15.77 |
| ESR1 SRX371478 | MCF-7 Breast | 306 / 11910 (2.6%) | 9542 / 119100 (8.0%) | −130.1 | −127.5 | 0.32 |
| CDK9 SRX7366783 | MCF-7 Breast | 199 / 11910 (1.7%) | 102 / 119100 (0.1%) | −129.6 | −127.0 | 19.51 |
| FOXA1 SRX371481 | MCF-7 Breast | 250 / 11910 (2.1%) | 8590 / 119100 (7.2%) | −129.5 | −126.9 | 0.29 |
| FOXA1 SRX371483 | MCF-7 Breast | 267 / 11910 (2.2%) | 8879 / 119100 (7.5%) | −129.4 | −126.8 | 0.30 |
| FOXA1 SRX371482 | MCF-7 Breast | 352 / 11910 (3.0%) | 10245 / 119100 (8.6%) | −129.1 | −126.5 | 0.34 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 225 / 11910 (1.9%) | 8114 / 119100 (6.8%) | −127.9 | −125.3 | 0.28 |
| ESR1 SRX371476 | MCF-7 Breast | 169 / 11910 (1.4%) | 7104 / 119100 (6.0%) | −127.6 | −125.0 | 0.24 |
| ESR1 SRX4367193 | MCF-7 Breast | 788 / 11910 (6.6%) | 16468 / 119100 (13.8%) | −126.8 | −124.2 | 0.48 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 413 / 11910 (3.5%) | 821 / 119100 (0.7%) | −125.8 | −123.2 | 5.03 |
| FOXA1 SRX1161177 | MCF-7 Breast | 239 / 11910 (2.0%) | 8287 / 119100 (7.0%) | −125.8 | −123.2 | 0.29 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 176 / 11910 (1.5%) | 7148 / 119100 (6.0%) | −124.8 | −122.2 | 0.25 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 217 / 11910 (1.8%) | 7872 / 119100 (6.6%) | −124.7 | −122.2 | 0.28 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 586 / 11910 (4.9%) | 13579 / 119100 (11.4%) | −124.6 | −122.0 | 0.43 |
| FOS SRX4192880 | MCF 10A Breast | 427 / 11910 (3.6%) | 11234 / 119100 (9.4%) | −124.3 | −121.7 | 0.38 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 334 / 11910 (2.8%) | 519 / 119100 (0.4%) | −124.1 | −121.6 | 6.44 |
| ESR1 SRX176860 | MCF-7 Breast | 405 / 11910 (3.4%) | 10873 / 119100 (9.1%) | −123.6 | −121.0 | 0.37 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 294 / 11910 (2.5%) | 9114 / 119100 (7.7%) | −123.1 | −120.6 | 0.32 |
| ESR1 SRX371471 | ZR-75-1 Breast | 269 / 11910 (2.3%) | 8703 / 119100 (7.3%) | −123.1 | −120.6 | 0.31 |
| ESR1 SRX176861 | MCF-7 Breast | 407 / 11910 (3.4%) | 10887 / 119100 (9.1%) | −123.1 | −120.5 | 0.37 |
| ESR1 SRX7624156 | MCF-7 Breast | 394 / 11910 (3.3%) | 10673 / 119100 (9.0%) | −122.6 | −120.1 | 0.37 |
| FOXA1 SRX1161173 | MCF-7 Breast | 185 / 11910 (1.6%) | 7234 / 119100 (6.1%) | −122.3 | −119.8 | 0.26 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 589 / 11910 (4.9%) | 13521 / 119100 (11.4%) | −122.1 | −119.5 | 0.44 |
| FOXA1 SRX1161176 | MCF-7 Breast | 234 / 11910 (2.0%) | 8044 / 119100 (6.8%) | −120.9 | −118.4 | 0.29 |
| TLE3 SRX4815191 | MCF-7 Breast | 241 / 11910 (2.0%) | 8160 / 119100 (6.9%) | −120.8 | −118.3 | 0.30 |
| GATA3 SRX190239 | MCF-7 Breast | 371 / 11910 (3.1%) | 10245 / 119100 (8.6%) | −120.6 | −118.1 | 0.36 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 374 / 11910 (3.1%) | 698 / 119100 (0.6%) | −120.3 | −117.8 | 5.36 |
| SS18 SRX3468047 | Fibroblasts Others | 629 / 11910 (5.3%) | 14017 / 119100 (11.8%) | −120.3 | −117.8 | 0.45 |
| ESR1 SRX20282961 | MCF-7 Breast | 316 / 11910 (2.7%) | 9363 / 119100 (7.9%) | −120.0 | −117.5 | 0.34 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 293 / 11910 (2.5%) | 8991 / 119100 (7.5%) | −119.9 | −117.4 | 0.33 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 613 / 11910 (5.1%) | 13750 / 119100 (11.5%) | −119.3 | −116.8 | 0.45 |
| ESR1 SRX371470 | ZR-75-1 Breast | 229 / 11910 (1.9%) | 7902 / 119100 (6.6%) | −119.2 | −116.7 | 0.29 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 433 / 11910 (3.6%) | 11135 / 119100 (9.3%) | −119.1 | −116.6 | 0.39 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 363 / 11910 (3.0%) | 10068 / 119100 (8.5%) | −119.0 | −116.6 | 0.36 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 335 / 11910 (2.8%) | 555 / 119100 (0.5%) | −118.6 | −116.2 | 6.04 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 222 / 11910 (1.9%) | 7747 / 119100 (6.5%) | −118.1 | −115.6 | 0.29 |
| 5-mC SRX882970 | LNCAP Prostate | 1930 / 11910 (16.2%) | 10851 / 119100 (9.1%) | −118.0 | −115.5 | 1.78 |
| RUNX1 SRX2513054 | 293 Kidney | 2173 / 11910 (18.2%) | 12751 / 119100 (10.7%) | −117.8 | −115.3 | 1.70 |
| FOS SRX150517 | MCF 10A Breast | 445 / 11910 (3.7%) | 11226 / 119100 (9.4%) | −116.7 | −114.2 | 0.40 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 183 / 11910 (1.5%) | 7023 / 119100 (5.9%) | −116.6 | −114.2 | 0.26 |
| ESR1 SRX1531791 | MCF-7 Breast | 236 / 11910 (2.0%) | 7928 / 119100 (6.7%) | −116.2 | −113.8 | 0.30 |
| ING5 SRX286202 | RKO Digestive tract | 929 / 11910 (7.8%) | 3763 / 119100 (3.2%) | −116.1 | −113.6 | 2.47 |
| ESR1 SRX194572 | MCF-7 Breast | 153 / 11910 (1.3%) | 6457 / 119100 (5.4%) | −116.0 | −113.6 | 0.24 |
| ESR1 SRX371477 | MCF-7 Breast | 112 / 11910 (0.9%) | 5672 / 119100 (4.8%) | −116.0 | −113.6 | 0.20 |
| RELA SRX2207673 | HUVEC Cardiovascular | 915 / 11910 (7.7%) | 17695 / 119100 (14.9%) | −115.9 | −113.5 | 0.52 |
| ESR1 SRX194569 | MCF-7 Breast | 264 / 11910 (2.2%) | 8382 / 119100 (7.0%) | −115.8 | −113.4 | 0.31 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 617 / 11910 (5.2%) | 1917 / 119100 (1.6%) | −115.7 | −113.3 | 3.22 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1397 / 11910 (11.7%) | 6949 / 119100 (5.8%) | −115.6 | −113.1 | 2.01 |
| ESR1 SRX371467 | MCF-7 Breast | 267 / 11910 (2.2%) | 8409 / 119100 (7.1%) | −115.2 | −112.8 | 0.32 |
| ESR1 SRX371479 | MCF-7 Breast | 237 / 11910 (2.0%) | 7899 / 119100 (6.6%) | −114.9 | −112.5 | 0.30 |
| SSRP1 SRX3436567 | HT-1080 Bone | 293 / 11910 (2.5%) | 425 / 119100 (0.4%) | −114.4 | −112.0 | 6.89 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 232 / 11910 (1.9%) | 7796 / 119100 (6.5%) | −114.3 | −111.9 | 0.30 |
| FOXA1 SRX100454 | T-47D Breast | 344 / 11910 (2.9%) | 9597 / 119100 (8.1%) | −114.1 | −111.7 | 0.36 |
| GATA3 SRX5057632 | MCF-7 Breast | 162 / 11910 (1.4%) | 6555 / 119100 (5.5%) | −113.7 | −111.3 | 0.25 |
| FOXA1 SRX028634 | MCF-7 Breast | 111 / 11910 (0.9%) | 5585 / 119100 (4.7%) | −113.6 | −111.2 | 0.20 |
| FOXA1 SRX371480 | MCF-7 Breast | 171 / 11910 (1.4%) | 6699 / 119100 (5.6%) | −113.2 | −110.8 | 0.26 |
| ESR1 SRX20282960 | MCF-7 Breast | 296 / 11910 (2.5%) | 8799 / 119100 (7.4%) | −112.8 | −110.4 | 0.34 |
| ESR1 SRX10365535 | MCF-7 Breast | 198 / 11910 (1.7%) | 7162 / 119100 (6.0%) | −112.7 | −110.3 | 0.28 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 872 / 11910 (7.3%) | 16982 / 119100 (14.3%) | −112.5 | −110.1 | 0.51 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 176 / 11910 (1.5%) | 6764 / 119100 (5.7%) | −112.4 | −110.1 | 0.26 |
| RAC1 SRX10365543 | MCF-7 Breast | 125 / 11910 (1.0%) | 5825 / 119100 (4.9%) | −112.4 | −110.1 | 0.21 |
| 5-mC SRX882968 | LNCAP Prostate | 1903 / 11910 (16.0%) | 10811 / 119100 (9.1%) | −112.4 | −110.0 | 1.76 |
| ESR1 SRX371468 | MCF-7 Breast | 161 / 11910 (1.4%) | 6485 / 119100 (5.4%) | −112.2 | −109.8 | 0.25 |
| TCF12 SRX190356 | SK-N-SH Neural | 705 / 11910 (5.9%) | 14732 / 119100 (12.4%) | −112.0 | −109.7 | 0.48 |
| GATA3 SRX190194 | SK-N-SH Neural | 619 / 11910 (5.2%) | 13521 / 119100 (11.4%) | −111.5 | −109.1 | 0.46 |
| FOXA1 SRX1161175 | MCF-7 Breast | 191 / 11910 (1.6%) | 6999 / 119100 (5.9%) | −111.4 | −109.0 | 0.27 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 574 / 11910 (4.8%) | 12888 / 119100 (10.8%) | −111.4 | −109.0 | 0.45 |
| ESR1 SRX10365536 | MCF-7 Breast | 128 / 11910 (1.1%) | 5836 / 119100 (4.9%) | −111.0 | −108.6 | 0.22 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 260 / 11910 (2.2%) | 8140 / 119100 (6.8%) | −110.6 | −108.2 | 0.32 |
| ESR1 SRX20282939 | MCF-7 Breast | 301 / 11910 (2.5%) | 8793 / 119100 (7.4%) | −110.5 | −108.1 | 0.34 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 204 / 11910 (1.7%) | 7194 / 119100 (6.0%) | −110.4 | −108.0 | 0.28 |
| RAC1 SRX10365541 | MCF-7 Breast | 131 / 11910 (1.1%) | 5871 / 119100 (4.9%) | −110.2 | −107.9 | 0.22 |
| RELA SRX2207672 | HUVEC Cardiovascular | 999 / 11910 (8.4%) | 18520 / 119100 (15.5%) | −110.0 | −107.6 | 0.54 |
| FOXA1 SRX3931043 | MCF-7 Breast | 264 / 11910 (2.2%) | 8158 / 119100 (6.8%) | −109.3 | −107.0 | 0.32 |
| GATA3 SRX176864 | MCF-7 Breast | 191 / 11910 (1.6%) | 6927 / 119100 (5.8%) | −109.2 | −106.9 | 0.28 |
| AR SRX1067071 | LHSAR Prostate | 515 / 11910 (4.3%) | 11956 / 119100 (10.0%) | −108.9 | −106.6 | 0.43 |
| FOXA1 SRX3923514 | MCF-7 Breast | 266 / 11910 (2.2%) | 8156 / 119100 (6.8%) | −108.2 | −105.8 | 0.33 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 514 / 11910 (4.3%) | 11898 / 119100 (10.0%) | −107.9 | −105.6 | 0.43 |
| FOXA1 SRX11222437 | MCF-7 Breast | 180 / 11910 (1.5%) | 6694 / 119100 (5.6%) | −107.8 | −105.5 | 0.27 |
| YAP1 SRX5718140 | 293 Kidney | 450 / 11910 (3.8%) | 10964 / 119100 (9.2%) | −107.7 | −105.4 | 0.41 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 283 / 11910 (2.4%) | 8402 / 119100 (7.1%) | −107.4 | −105.1 | 0.34 |
| EP300 SRX2671813 | Fibroblasts Others | 214 / 11910 (1.8%) | 7248 / 119100 (6.1%) | −106.9 | −104.6 | 0.30 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 400 / 11910 (3.4%) | 10171 / 119100 (8.5%) | −106.3 | −104.0 | 0.39 |
| NR3C1 SRX2609664 | HASM2 Lung | 371 / 11910 (3.1%) | 9732 / 119100 (8.2%) | −106.3 | −103.9 | 0.38 |
| LEO1 SRX1873456 | SEM Blood | 1011 / 11910 (8.5%) | 4488 / 119100 (3.8%) | −106.0 | −103.7 | 2.25 |
| FOXA1 SRX3931054 | MCF-7 Breast | 246 / 11910 (2.1%) | 7747 / 119100 (6.5%) | −105.8 | −103.5 | 0.32 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 239 / 11910 (2.0%) | 7626 / 119100 (6.4%) | −105.7 | −103.4 | 0.31 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 349 / 11910 (2.9%) | 9358 / 119100 (7.9%) | −105.2 | −102.9 | 0.37 |
| ESR1 SRX20282972 | MCF-7 Breast | 299 / 11910 (2.5%) | 8573 / 119100 (7.2%) | −105.1 | −102.8 | 0.35 |
| FOXA2 SRX3230382 | Hep G2 Liver | 378 / 11910 (3.2%) | 9793 / 119100 (8.2%) | −105.0 | −102.7 | 0.39 |
| ESR1 SRX20282954 | MCF-7 Breast | 293 / 11910 (2.5%) | 8475 / 119100 (7.1%) | −104.9 | −102.6 | 0.35 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 346 / 11910 (2.9%) | 9294 / 119100 (7.8%) | −104.7 | −102.4 | 0.37 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 184 / 11910 (1.5%) | 6651 / 119100 (5.6%) | −104.3 | −102.0 | 0.28 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 705 / 11910 (5.9%) | 14397 / 119100 (12.1%) | −104.1 | −101.8 | 0.49 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 795 / 11910 (6.7%) | 15570 / 119100 (13.1%) | −103.5 | −101.2 | 0.51 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 893 / 11910 (7.5%) | 16855 / 119100 (14.2%) | −103.4 | −101.1 | 0.53 |
| 5-mC SRX882965 | LNCAP Prostate | 1546 / 11910 (13.0%) | 8389 / 119100 (7.0%) | −102.4 | −100.2 | 1.84 |
| ETS1 SRX3033231 | HEYA8 Gonad | 216 / 11910 (1.8%) | 230 / 119100 (0.2%) | −102.3 | −100.0 | 9.39 |
| NR3C1 SRX2609665 | HASM2 Lung | 300 / 11910 (2.5%) | 8486 / 119100 (7.1%) | −102.1 | −99.8 | 0.35 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 254 / 11910 (2.1%) | 7747 / 119100 (6.5%) | −102.0 | −99.7 | 0.33 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 678 / 11910 (5.7%) | 13939 / 119100 (11.7%) | −102.0 | −99.7 | 0.49 |
| FOXA1 SRX3931055 | MCF-7 Breast | 228 / 11910 (1.9%) | 7304 / 119100 (6.1%) | −101.5 | −99.2 | 0.31 |
| FOS SRX150476 | MCF 10A Breast | 482 / 11910 (4.0%) | 11184 / 119100 (9.4%) | −101.4 | −99.2 | 0.43 |
| FOXA1 SRX5323843 | MCF-7 Breast | 134 / 11910 (1.1%) | 5655 / 119100 (4.7%) | −101.2 | −99.0 | 0.24 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 461 / 11910 (3.9%) | 10874 / 119100 (9.1%) | −101.2 | −98.9 | 0.42 |
| FOXA1 SRX028635 | MCF-7 Breast | 126 / 11910 (1.1%) | 5500 / 119100 (4.6%) | −100.9 | −98.7 | 0.23 |
| FOXA1 SRX11222441 | MCF-7 Breast | 210 / 11910 (1.8%) | 6985 / 119100 (5.9%) | −100.9 | −98.7 | 0.30 |
| ESR1 SRX371475 | BT-474 Breast | 136 / 11910 (1.1%) | 5675 / 119100 (4.8%) | −100.6 | −98.4 | 0.24 |
| FOXA1 SRX1787655 | MCF-7 Breast | 131 / 11910 (1.1%) | 5580 / 119100 (4.7%) | −100.6 | −98.3 | 0.23 |
| FOXA1 SRX1787653 | MCF-7 Breast | 222 / 11910 (1.9%) | 7166 / 119100 (6.0%) | −100.4 | −98.1 | 0.31 |
| AR SRX9469988 | LAPC-4 Prostate | 369 / 11910 (3.1%) | 9475 / 119100 (8.0%) | −100.1 | −97.9 | 0.39 |
| ESR1 SRX10365532 | MCF-7 Breast | 141 / 11910 (1.2%) | 5745 / 119100 (4.8%) | −100.0 | −97.7 | 0.25 |
| LARP7 SRX2198835 | HeLa Uterus | 1437 / 11910 (12.1%) | 7657 / 119100 (6.4%) | −99.7 | −97.4 | 1.88 |
| ESR1 SRX2943591 | MCF-7 Breast | 194 / 11910 (1.6%) | 6663 / 119100 (5.6%) | −99.3 | −97.1 | 0.29 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 153 / 11910 (1.3%) | 80 / 119100 (0.1%) | −99.1 | −96.9 | 19.13 |
| FOXA1 SRX100506 | Hep G2 Liver | 379 / 11910 (3.2%) | 9585 / 119100 (8.0%) | −99.0 | −96.8 | 0.40 |
| FOXA1 SRX1161174 | MCF-7 Breast | 291 / 11910 (2.4%) | 8219 / 119100 (6.9%) | −98.5 | −96.3 | 0.35 |
| FOXA2 SRX100448 | Hep G2 Liver | 315 / 11910 (2.6%) | 8586 / 119100 (7.2%) | −98.3 | −96.1 | 0.37 |
| JUN SRX6582171 | GM07492 Others | 542 / 11910 (4.6%) | 11892 / 119100 (10.0%) | −97.8 | −95.6 | 0.46 |
| FOXA1 SRX1787652 | MCF-7 Breast | 165 / 11910 (1.4%) | 6103 / 119100 (5.1%) | −97.5 | −95.3 | 0.27 |
| FOXA1 SRX1787651 | MCF-7 Breast | 151 / 11910 (1.3%) | 5842 / 119100 (4.9%) | −97.3 | −95.1 | 0.26 |
| JUN SRX17561461 | LPS141 Adipocyte | 408 / 11910 (3.4%) | 9945 / 119100 (8.4%) | −97.2 | −95.0 | 0.41 |
| NR3C1 SRX2609662 | HASM2 Lung | 335 / 11910 (2.8%) | 8849 / 119100 (7.4%) | −97.1 | −94.9 | 0.38 |
| FOXA1 SRX1447317 | MCF-7 Breast | 179 / 11910 (1.5%) | 6328 / 119100 (5.3%) | −97.1 | −94.8 | 0.28 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 146 / 11910 (1.2%) | 71 / 119100 (0.1%) | −96.9 | −94.7 | 20.56 |
| ESR1 SRX330069 | MCF-7 Breast | 166 / 11910 (1.4%) | 6076 / 119100 (5.1%) | −96.2 | −94.0 | 0.27 |
| ESR1 SRX371474 | BT-474 Breast | 130 / 11910 (1.1%) | 5423 / 119100 (4.6%) | −96.0 | −93.8 | 0.24 |
| ESR1 SRX20282946 | MCF-7 Breast | 168 / 11910 (1.4%) | 6101 / 119100 (5.1%) | −96.0 | −93.7 | 0.28 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 272 / 11910 (2.3%) | 7823 / 119100 (6.6%) | −95.9 | −93.7 | 0.35 |
| ESR1 SRX20282955 | MCF-7 Breast | 300 / 11910 (2.5%) | 8264 / 119100 (6.9%) | −95.9 | −93.7 | 0.36 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 155 / 11910 (1.3%) | 5862 / 119100 (4.9%) | −95.6 | −93.4 | 0.26 |
| FOXA1 SRX15430999 | T-47D Breast | 314 / 11910 (2.6%) | 8471 / 119100 (7.1%) | −95.5 | −93.3 | 0.37 |
| AR SRX1067070 | LHSAR Prostate | 681 / 11910 (5.7%) | 13701 / 119100 (11.5%) | −95.5 | −93.3 | 0.50 |
| ESR1 SRX330067 | MCF-7 Breast | 251 / 11910 (2.1%) | 7474 / 119100 (6.3%) | −95.5 | −93.3 | 0.34 |
| ESR1 SRX10365558 | MCF-7 Breast | 183 / 11910 (1.5%) | 6349 / 119100 (5.3%) | −95.5 | −93.3 | 0.29 |
| ESR1 SRX2881000 | MCF-7 Breast | 247 / 11910 (2.1%) | 7406 / 119100 (6.2%) | −95.4 | −93.2 | 0.33 |
| Epitope tags SRX5877912 | U2OS Bone | 1547 / 11910 (13.0%) | 24547 / 119100 (20.6%) | −95.3 | −93.1 | 0.63 |
| FOXA1 SRX11222438 | MCF-7 Breast | 148 / 11910 (1.2%) | 5722 / 119100 (4.8%) | −95.1 | −92.9 | 0.26 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 503 / 11910 (4.2%) | 1551 / 119100 (1.3%) | −95.0 | −92.9 | 3.24 |
| FOXA1 SRX11222442 | MCF-7 Breast | 189 / 11910 (1.6%) | 6432 / 119100 (5.4%) | −95.0 | −92.8 | 0.29 |
| FOXA1 SRX3923517 | MCF-7 Breast | 197 / 11910 (1.7%) | 6564 / 119100 (5.5%) | −94.9 | −92.7 | 0.30 |
| NR3C1 SRX2609666 | HASM2 Lung | 271 / 11910 (2.3%) | 7767 / 119100 (6.5%) | −94.7 | −92.5 | 0.35 |
| FOXA1 SRX3931033 | MCF-7 Breast | 179 / 11910 (1.5%) | 6250 / 119100 (5.2%) | −94.6 | −92.5 | 0.29 |
| MAU2 SRX15710550 | Fibroblasts Others | 467 / 11910 (3.9%) | 10698 / 119100 (9.0%) | −94.5 | −92.3 | 0.44 |
| FOXA1 SRX3923516 | MCF-7 Breast | 203 / 11910 (1.7%) | 6650 / 119100 (5.6%) | −94.4 | −92.2 | 0.31 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 381 / 11910 (3.2%) | 9439 / 119100 (7.9%) | −94.4 | −92.2 | 0.40 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 191 / 11910 (1.6%) | 6445 / 119100 (5.4%) | −94.3 | −92.2 | 0.30 |
| FOS SRX4192879 | MCF 10A Breast | 339 / 11910 (2.8%) | 8804 / 119100 (7.4%) | −94.2 | −92.0 | 0.39 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 889 / 11910 (7.5%) | 3919 / 119100 (3.3%) | −94.2 | −92.0 | 2.27 |
| ESR1 SRX4451213 | MCF-7 Breast | 285 / 11910 (2.4%) | 7969 / 119100 (6.7%) | −94.1 | −92.0 | 0.36 |
| ARID5B SRX3230377 | Hep G2 Liver | 722 / 11910 (6.1%) | 14181 / 119100 (11.9%) | −93.9 | −91.7 | 0.51 |
| FOXA1 SRX1161203 | T-47D Breast | 207 / 11910 (1.7%) | 6699 / 119100 (5.6%) | −93.9 | −91.7 | 0.31 |
| FOXA1 SRX1447316 | MCF-7 Breast | 114 / 11910 (1.0%) | 5050 / 119100 (4.2%) | −93.7 | −91.6 | 0.23 |
| TP53 SRX396254 | Fibroblasts Others | 585 / 11910 (4.9%) | 2032 / 119100 (1.7%) | −93.4 | −91.3 | 2.88 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 482 / 11910 (4.0%) | 1458 / 119100 (1.2%) | −93.4 | −91.2 | 3.31 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 191 / 11910 (1.6%) | 6412 / 119100 (5.4%) | −93.2 | −91.0 | 0.30 |
| SSRP1 SRX3436566 | HT-1080 Bone | 213 / 11910 (1.8%) | 260 / 119100 (0.2%) | −93.2 | −91.0 | 8.19 |
| ESR1 SRX3110725 | MCF-7 Breast | 253 / 11910 (2.1%) | 7429 / 119100 (6.2%) | −93.2 | −91.0 | 0.34 |
| Epitope tags SRX10549778 | K-562 Blood | 738 / 11910 (6.2%) | 2959 / 119100 (2.5%) | −93.1 | −91.0 | 2.49 |
| ESR1 SRX2881002 | MCF-7 Breast | 270 / 11910 (2.3%) | 7694 / 119100 (6.5%) | −93.1 | −90.9 | 0.35 |
| NR3C1 SRX2609659 | HASM2 Lung | 338 / 11910 (2.8%) | 8746 / 119100 (7.3%) | −93.0 | −90.9 | 0.39 |
| FOXA1 SRX5203303 | MCF-7 Breast | 93 / 11910 (0.8%) | 4621 / 119100 (3.9%) | −92.9 | −90.8 | 0.20 |
| ESR1 SRX20282973 | MCF-7 Breast | 351 / 11910 (2.9%) | 8928 / 119100 (7.5%) | −92.7 | −90.6 | 0.39 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 386 / 11910 (3.2%) | 9448 / 119100 (7.9%) | −92.7 | −90.6 | 0.41 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 528 / 11910 (4.4%) | 1720 / 119100 (1.4%) | −92.5 | −90.4 | 3.07 |
| EP300 SRX176885 | MCF-7 Breast | 146 / 11910 (1.2%) | 5603 / 119100 (4.7%) | −92.5 | −90.3 | 0.26 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1118 / 11910 (9.4%) | 5547 / 119100 (4.7%) | −91.7 | −89.6 | 2.02 |
| JUNB SRX8488088 | SUM 229PE Breast | 559 / 11910 (4.7%) | 11870 / 119100 (10.0%) | −91.6 | −89.5 | 0.47 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 424 / 11910 (3.6%) | 9964 / 119100 (8.4%) | −91.6 | −89.5 | 0.43 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 894 / 11910 (7.5%) | 16319 / 119100 (13.7%) | −91.6 | −89.5 | 0.55 |
| FOXA1 SRX3931056 | MCF-7 Breast | 170 / 11910 (1.4%) | 5992 / 119100 (5.0%) | −91.4 | −89.3 | 0.28 |
| JUNB SRX8488073 | SUM 229PE Breast | 538 / 11910 (4.5%) | 11567 / 119100 (9.7%) | −91.3 | −89.2 | 0.47 |
| FOXA1 SRX3931032 | MCF-7 Breast | 166 / 11910 (1.4%) | 5910 / 119100 (5.0%) | −91.0 | −88.9 | 0.28 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 151 / 11910 (1.3%) | 97 / 119100 (0.1%) | −90.8 | −88.7 | 15.57 |
| ESR1 SRX4367192 | MCF-7 Breast | 581 / 11910 (4.9%) | 12135 / 119100 (10.2%) | −90.6 | −88.5 | 0.48 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 439 / 11910 (3.7%) | 10134 / 119100 (8.5%) | −90.4 | −88.3 | 0.43 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 434 / 11910 (3.6%) | 10054 / 119100 (8.4%) | −90.3 | −88.2 | 0.43 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 219 / 11910 (1.8%) | 6776 / 119100 (5.7%) | −90.2 | −88.1 | 0.32 |
| SMARCA2 SRX8119677 | MeT-5A Others | 479 / 11910 (4.0%) | 10672 / 119100 (9.0%) | −89.7 | −87.6 | 0.45 |
| AR SRX9109110 | MDA-MB-453 Breast | 545 / 11910 (4.6%) | 11597 / 119100 (9.7%) | −89.7 | −87.6 | 0.47 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 192 / 11910 (1.6%) | 6309 / 119100 (5.3%) | −89.7 | −87.6 | 0.30 |
| ESR1 SRX10365533 | MCF-7 Breast | 138 / 11910 (1.2%) | 5364 / 119100 (4.5%) | −89.4 | −87.3 | 0.26 |
| TLE3 SRX4815192 | MCF-7 Breast | 272 / 11910 (2.3%) | 7594 / 119100 (6.4%) | −89.4 | −87.3 | 0.36 |
| Epitope tags SRX5877914 | U2OS Bone | 1558 / 11910 (13.1%) | 24352 / 119100 (20.4%) | −89.2 | −87.1 | 0.64 |
| FOXA1 SRX1961158 | T-47D Breast | 293 / 11910 (2.5%) | 7915 / 119100 (6.6%) | −89.2 | −87.1 | 0.37 |
| JUN SRX4192884 | MCF 10A Breast | 254 / 11910 (2.1%) | 7304 / 119100 (6.1%) | −89.1 | −87.0 | 0.35 |
| CEBPB SRX150632 | HeLa Uterus | 654 / 11910 (5.5%) | 13059 / 119100 (11.0%) | −89.1 | −87.0 | 0.50 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 326 / 11910 (2.7%) | 8415 / 119100 (7.1%) | −89.1 | −87.0 | 0.39 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 257 / 11910 (2.2%) | 7343 / 119100 (6.2%) | −89.0 | −86.9 | 0.35 |
| NANOG SRX10445309 | Neural crest cells Neural | 158 / 11910 (1.3%) | 5703 / 119100 (4.8%) | −89.0 | −86.9 | 0.28 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 289 / 11910 (2.4%) | 7843 / 119100 (6.6%) | −88.9 | −86.8 | 0.37 |
| FOXA1 SRX5323845 | MCF-7 Breast | 105 / 11910 (0.9%) | 4733 / 119100 (4.0%) | −88.8 | −86.7 | 0.22 |
| ESR1 SRX1012629 | MCF-7 Breast | 181 / 11910 (1.5%) | 6094 / 119100 (5.1%) | −88.8 | −86.7 | 0.30 |
| CIC SRX13262055 | Astrocytes Neural | 1955 / 11910 (16.4%) | 12031 / 119100 (10.1%) | −88.7 | −86.6 | 1.62 |
| ESR1 SRX20282953 | MCF-7 Breast | 242 / 11910 (2.0%) | 7090 / 119100 (6.0%) | −88.6 | −86.5 | 0.34 |
| FOXA1 SRX1961157 | T-47D Breast | 324 / 11910 (2.7%) | 8363 / 119100 (7.0%) | −88.5 | −86.5 | 0.39 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 371 / 11910 (3.1%) | 945 / 119100 (0.8%) | −88.3 | −86.2 | 3.93 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 148 / 11910 (1.2%) | 5505 / 119100 (4.6%) | −88.3 | −86.2 | 0.27 |
| FOXA1 SRX3923519 | MCF-7 Breast | 180 / 11910 (1.5%) | 6058 / 119100 (5.1%) | −88.2 | −86.2 | 0.30 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 383 / 11910 (3.2%) | 9230 / 119100 (7.7%) | −88.2 | −86.1 | 0.41 |
| FOXA1 SRX3923518 | MCF-7 Breast | 204 / 11910 (1.7%) | 6460 / 119100 (5.4%) | −88.1 | −86.1 | 0.32 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 264 / 11910 (2.2%) | 7421 / 119100 (6.2%) | −88.1 | −86.0 | 0.36 |
| CEBPB SRX190345 | MCF-7 Breast | 227 / 11910 (1.9%) | 6829 / 119100 (5.7%) | −88.0 | −86.0 | 0.33 |
| ESR1 SRX8537722 | MCF-7 Breast | 270 / 11910 (2.3%) | 7510 / 119100 (6.3%) | −87.9 | −85.9 | 0.36 |
| ESR1 SRX20282940 | MCF-7 Breast | 327 / 11910 (2.7%) | 8381 / 119100 (7.0%) | −87.8 | −85.7 | 0.39 |
| TEAD1 SRX3401272 | MCF-7 Breast | 237 / 11910 (2.0%) | 6985 / 119100 (5.9%) | −87.8 | −85.7 | 0.34 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 268 / 11910 (2.3%) | 7472 / 119100 (6.3%) | −87.6 | −85.6 | 0.36 |
| PROX1 SRX3230397 | Hep G2 Liver | 225 / 11910 (1.9%) | 6781 / 119100 (5.7%) | −87.5 | −85.5 | 0.33 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 284 / 11910 (2.4%) | 7713 / 119100 (6.5%) | −87.4 | −85.4 | 0.37 |
| ARID1A SRX5089376 | MCF-7 Breast | 268 / 11910 (2.3%) | 7460 / 119100 (6.3%) | −87.4 | −85.3 | 0.36 |
| FOXA1 SRX5203294 | MCF-7 Breast | 83 / 11910 (0.7%) | 4259 / 119100 (3.6%) | −87.3 | −85.2 | 0.19 |
| FOXA1 SRX5323829 | T-47D Breast | 168 / 11910 (1.4%) | 5821 / 119100 (4.9%) | −87.3 | −85.2 | 0.29 |
| FOXA2 SRX10475773 | Hep G2 Liver | 372 / 11910 (3.1%) | 9023 / 119100 (7.6%) | −87.1 | −85.0 | 0.41 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 147 / 11910 (1.2%) | 5447 / 119100 (4.6%) | −87.1 | −85.0 | 0.27 |
| GATAD2A SRX2636506 | Hep G2 Liver | 395 / 11910 (3.3%) | 9360 / 119100 (7.9%) | −87.0 | −84.9 | 0.42 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 379 / 11910 (3.2%) | 9121 / 119100 (7.7%) | −86.8 | −84.8 | 0.42 |
| ESR1 SRX330070 | MCF-7 Breast | 152 / 11910 (1.3%) | 5528 / 119100 (4.6%) | −86.8 | −84.8 | 0.27 |
| CEBPA SRX2630241 | Hep G2 Liver | 371 / 11910 (3.1%) | 9001 / 119100 (7.6%) | −86.8 | −84.8 | 0.41 |
| SMARCA4 SRX5212362 | Mel270 Others | 513 / 11910 (4.3%) | 11025 / 119100 (9.3%) | −86.7 | −84.6 | 0.47 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 249 / 11910 (2.1%) | 7134 / 119100 (6.0%) | −86.6 | −84.6 | 0.35 |
| FOXA1 SRX3923515 | MCF-7 Breast | 167 / 11910 (1.4%) | 5783 / 119100 (4.9%) | −86.6 | −84.5 | 0.29 |
| GATA3 SRX6712581 | MCF-7 Breast | 250 / 11910 (2.1%) | 7145 / 119100 (6.0%) | −86.5 | −84.5 | 0.35 |
| ESR1 SRX5323871 | MCF-7 Breast | 322 / 11910 (2.7%) | 8256 / 119100 (6.9%) | −86.5 | −84.4 | 0.39 |
| FOXA1 SRX190181 | A549 Lung | 221 / 11910 (1.9%) | 6673 / 119100 (5.6%) | −86.4 | −84.3 | 0.33 |
| FOXA1 SRX1787654 | MCF-7 Breast | 110 / 11910 (0.9%) | 4750 / 119100 (4.0%) | −86.3 | −84.2 | 0.23 |
| GATA3 SRX100559 | T-47D Breast | 342 / 11910 (2.9%) | 8550 / 119100 (7.2%) | −86.3 | −84.2 | 0.40 |
| FOXA1 SRX1161207 | T-47D Breast | 123 / 11910 (1.0%) | 4989 / 119100 (4.2%) | −86.2 | −84.1 | 0.25 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 625 / 11910 (5.2%) | 12537 / 119100 (10.5%) | −86.2 | −84.1 | 0.50 |
| ESR1 SRX20282959 | MCF-7 Breast | 122 / 11910 (1.0%) | 4964 / 119100 (4.2%) | −85.9 | −83.9 | 0.25 |
| ESR1 SRX1012632 | MCF-7 Breast | 150 / 11910 (1.3%) | 5463 / 119100 (4.6%) | −85.9 | −83.9 | 0.27 |
| SOX13 SRX2636248 | Hep G2 Liver | 428 / 11910 (3.6%) | 9795 / 119100 (8.2%) | −85.9 | −83.9 | 0.44 |
| MEAF6 DRX234811 | 293 Kidney | 1072 / 11910 (9.0%) | 5368 / 119100 (4.5%) | −85.9 | −83.8 | 2.00 |
| ESR1 SRX4451212 | MCF-7 Breast | 280 / 11910 (2.4%) | 7593 / 119100 (6.4%) | −85.9 | −83.8 | 0.37 |
| AR SRX9109113 | MDA-MB-453 Breast | 564 / 11910 (4.7%) | 11697 / 119100 (9.8%) | −85.8 | −83.8 | 0.48 |
| CDK9 SRX7366779 | MCF-7 Breast | 140 / 11910 (1.2%) | 86 / 119100 (0.1%) | −85.7 | −83.6 | 16.28 |
| PGR SRX1012655 | MCF-7 Breast | 190 / 11910 (1.6%) | 6138 / 119100 (5.2%) | −85.6 | −83.6 | 0.31 |
| FOXA1 SRX6878603 | LNCAP Prostate | 337 / 11910 (2.8%) | 8446 / 119100 (7.1%) | −85.6 | −83.5 | 0.40 |
| FOXA1 SRX100477 | Hep G2 Liver | 354 / 11910 (3.0%) | 8697 / 119100 (7.3%) | −85.5 | −83.5 | 0.41 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 255 / 11910 (2.1%) | 7186 / 119100 (6.0%) | −85.4 | −83.4 | 0.35 |
| ESR1 SRX20282971 | MCF-7 Breast | 299 / 11910 (2.5%) | 7865 / 119100 (6.6%) | −85.3 | −83.3 | 0.38 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 272 / 11910 (2.3%) | 7446 / 119100 (6.3%) | −85.3 | −83.3 | 0.37 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 828 / 11910 (7.0%) | 15164 / 119100 (12.7%) | −85.2 | −83.2 | 0.55 |
| Epitope tags SRX10549777 | K-562 Blood | 1605 / 11910 (13.5%) | 9379 / 119100 (7.9%) | −85.1 | −83.1 | 1.71 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 208 / 11910 (1.7%) | 6417 / 119100 (5.4%) | −85.1 | −83.1 | 0.32 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 668 / 11910 (5.6%) | 13061 / 119100 (11.0%) | −85.0 | −83.0 | 0.51 |
| ESR1 SRX330068 | MCF-7 Breast | 143 / 11910 (1.2%) | 5310 / 119100 (4.5%) | −85.0 | −83.0 | 0.27 |
| ESR1 SRX5323873 | MCF-7 Breast | 368 / 11910 (3.1%) | 8880 / 119100 (7.5%) | −84.9 | −82.9 | 0.41 |
| ESR1 SRX1469949 | MCF-7 Breast | 172 / 11910 (1.4%) | 5806 / 119100 (4.9%) | −84.7 | −82.7 | 0.30 |
| ESR1 SRX3123829 | MCF-7 Breast | 177 / 11910 (1.5%) | 5889 / 119100 (4.9%) | −84.7 | −82.7 | 0.30 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 323 / 11910 (2.7%) | 8202 / 119100 (6.9%) | −84.6 | −82.6 | 0.39 |
| ESR1 SRX2912055 | MCF-7 Breast | 117 / 11910 (1.0%) | 4826 / 119100 (4.1%) | −84.5 | −82.5 | 0.24 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 292 / 11910 (2.5%) | 7722 / 119100 (6.5%) | −84.4 | −82.4 | 0.38 |
| ESR1 SRX2943589 | MCF-7 Breast | 161 / 11910 (1.4%) | 5597 / 119100 (4.7%) | −84.1 | −82.1 | 0.29 |
| HMG20A SRX2630163 | Hep G2 Liver | 181 / 11910 (1.5%) | 5936 / 119100 (5.0%) | −84.0 | −82.0 | 0.30 |
| NR3C1 SRX2609661 | HASM2 Lung | 342 / 11910 (2.9%) | 8461 / 119100 (7.1%) | −84.0 | −82.0 | 0.40 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 313 / 11910 (2.6%) | 712 / 119100 (0.6%) | −83.9 | −81.9 | 4.40 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 431 / 11910 (3.6%) | 9748 / 119100 (8.2%) | −83.7 | −81.7 | 0.44 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 283 / 11910 (2.4%) | 7557 / 119100 (6.3%) | −83.7 | −81.7 | 0.37 |
| ESR1 SRX10365534 | MCF-7 Breast | 90 / 11910 (0.8%) | 4288 / 119100 (3.6%) | −83.6 | −81.6 | 0.21 |
| FOXA1 SRX5203307 | MCF-7 Breast | 91 / 11910 (0.8%) | 4303 / 119100 (3.6%) | −83.5 | −81.5 | 0.21 |
| ESR1 SRX20282938 | MCF-7 Breast | 249 / 11910 (2.1%) | 7018 / 119100 (5.9%) | −83.3 | −81.3 | 0.35 |
| ESR1 SRX2513517 | MCF-7 Breast | 206 / 11910 (1.7%) | 6327 / 119100 (5.3%) | −83.3 | −81.3 | 0.33 |
| WWTR1 SRX10119367 | MCF 10A Breast | 360 / 11910 (3.0%) | 8700 / 119100 (7.3%) | −83.3 | −81.3 | 0.41 |
| FOXA1 SRX5323846 | MCF-7 Breast | 117 / 11910 (1.0%) | 4788 / 119100 (4.0%) | −83.2 | −81.2 | 0.24 |
| FOXA1 SRX2642368 | VCaP Prostate | 378 / 11910 (3.2%) | 8945 / 119100 (7.5%) | −82.8 | −80.8 | 0.42 |
| ESR1 SRX2513520 | MCF-7 Breast | 192 / 11910 (1.6%) | 6077 / 119100 (5.1%) | −82.8 | −80.8 | 0.32 |
| TFAP2C SRX018833 | MCF-7 Breast | 284 / 11910 (2.4%) | 7539 / 119100 (6.3%) | −82.8 | −80.8 | 0.38 |
| FOXA1 SRX1161205 | T-47D Breast | 169 / 11910 (1.4%) | 5683 / 119100 (4.8%) | −82.6 | −80.6 | 0.30 |
| FOXL2 SRX6957431 | KGN Gonad | 684 / 11910 (5.7%) | 13166 / 119100 (11.1%) | −82.6 | −80.6 | 0.52 |
| ESR1 SRX1531796 | MCF-7 Breast | 167 / 11910 (1.4%) | 5647 / 119100 (4.7%) | −82.5 | −80.5 | 0.30 |
| EP300 SRX1012648 | MCF-7 Breast | 150 / 11910 (1.3%) | 5354 / 119100 (4.5%) | −82.5 | −80.5 | 0.28 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 292 / 11910 (2.5%) | 7653 / 119100 (6.4%) | −82.5 | −80.5 | 0.38 |
| ESR1 SRX2513521 | MCF-7 Breast | 145 / 11910 (1.2%) | 5262 / 119100 (4.4%) | −82.3 | −80.3 | 0.28 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 337 / 11910 (2.8%) | 8320 / 119100 (7.0%) | −82.2 | −80.2 | 0.41 |
| RBFOX2 SRX4708082 | K-562 Blood | 1534 / 11910 (12.9%) | 8932 / 119100 (7.5%) | −82.0 | −80.1 | 1.72 |
| ESR1 SRX8537723 | MCF-7 Breast | 248 / 11910 (2.1%) | 6953 / 119100 (5.8%) | −82.0 | −80.1 | 0.36 |
| NR2F2 SRX190293 | MCF-7 Breast | 327 / 11910 (2.7%) | 8161 / 119100 (6.9%) | −82.0 | −80.1 | 0.40 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 585 / 11910 (4.9%) | 11811 / 119100 (9.9%) | −82.0 | −80.0 | 0.50 |
| ARID5B SRX10475139 | Hep G2 Liver | 349 / 11910 (2.9%) | 8484 / 119100 (7.1%) | −81.9 | −80.0 | 0.41 |
| ARID1A SRX5089379 | MCF-7 Breast | 311 / 11910 (2.6%) | 7917 / 119100 (6.6%) | −81.9 | −80.0 | 0.39 |
| PRRX1 SRX15235713 | Hs 578T Breast | 379 / 11910 (3.2%) | 8924 / 119100 (7.5%) | −81.8 | −79.9 | 0.42 |
| YAP1 SRX10119364 | MCF 10A Breast | 265 / 11910 (2.2%) | 7212 / 119100 (6.1%) | −81.8 | −79.8 | 0.37 |
| STAT1 SRX23678708 | K-562 Blood | 984 / 11910 (8.3%) | 4845 / 119100 (4.1%) | −81.7 | −79.8 | 2.03 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 394 / 11910 (3.3%) | 9130 / 119100 (7.7%) | −81.6 | −79.7 | 0.43 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 277 / 11910 (2.3%) | 7388 / 119100 (6.2%) | −81.6 | −79.6 | 0.37 |
| ESR1 SRX792933 | LY2 Breast | 255 / 11910 (2.1%) | 7044 / 119100 (5.9%) | −81.5 | −79.6 | 0.36 |
| JUNB SRX10119386 | MCF 10A Breast | 293 / 11910 (2.5%) | 7628 / 119100 (6.4%) | −81.5 | −79.5 | 0.38 |
| TFAP2C SRX128099 | MCF-7 Breast | 286 / 11910 (2.4%) | 7519 / 119100 (6.3%) | −81.4 | −79.4 | 0.38 |
| AR SRX1067066 | LHSAR Prostate | 638 / 11910 (5.4%) | 12493 / 119100 (10.5%) | −81.2 | −79.3 | 0.51 |
| PBX3 SRX190343 | SK-N-SH Neural | 631 / 11910 (5.3%) | 12390 / 119100 (10.4%) | −81.0 | −79.1 | 0.51 |
| FOXA1 SRX2642365 | VCaP Prostate | 296 / 11910 (2.5%) | 7657 / 119100 (6.4%) | −81.0 | −79.0 | 0.39 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 324 / 11910 (2.7%) | 8079 / 119100 (6.8%) | −81.0 | −79.0 | 0.40 |
| SMARCA4 SRX5212371 | Mel270 Others | 438 / 11910 (3.7%) | 9729 / 119100 (8.2%) | −80.9 | −78.9 | 0.45 |
| ESR1 SRX5323878 | MCF-7 Breast | 308 / 11910 (2.6%) | 7836 / 119100 (6.6%) | −80.9 | −78.9 | 0.39 |
| CBX3 SRX055348 | HCT 116 Digestive tract | 245 / 11910 (2.1%) | 444 / 119100 (0.4%) | −80.9 | −78.9 | 5.52 |
| FOXA1 SRX3931031 | MCF-7 Breast | 151 / 11910 (1.3%) | 5312 / 119100 (4.5%) | −80.7 | −78.8 | 0.28 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 117 / 11910 (1.0%) | 4709 / 119100 (4.0%) | −80.7 | −78.8 | 0.25 |
| YAP1 SRX1038945 | IMR-90 Lung | 238 / 11910 (2.0%) | 6745 / 119100 (5.7%) | −80.6 | −78.7 | 0.35 |
| SMAD1 SRX097097 | U-937 Blood | 192 / 11910 (1.6%) | 5999 / 119100 (5.0%) | −80.5 | −78.5 | 0.32 |
| VGLL1 SRX24602130 | BT-20 Breast | 341 / 11910 (2.9%) | 8307 / 119100 (7.0%) | −80.4 | −78.5 | 0.41 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1028 / 11910 (8.6%) | 17450 / 119100 (14.7%) | −80.2 | −78.3 | 0.59 |
| CEBPB SRX1027439 | Mesenchymal stem cells Others | 243 / 11910 (2.0%) | 6811 / 119100 (5.7%) | −80.2 | −78.3 | 0.36 |
| ESR1 SRX1012630 | MCF-7 Breast | 123 / 11910 (1.0%) | 4803 / 119100 (4.0%) | −80.2 | −78.2 | 0.26 |
| EP300 SRX100540 | SK-N-SH Neural | 449 / 11910 (3.8%) | 9858 / 119100 (8.3%) | −80.2 | −78.2 | 0.46 |
| FOXA1 SRX9604647 | LNCAP Prostate | 468 / 11910 (3.9%) | 10120 / 119100 (8.5%) | −80.1 | −78.2 | 0.46 |
| FOXA1 SRX1033292 | LNCAP Prostate | 169 / 11910 (1.4%) | 5600 / 119100 (4.7%) | −80.1 | −78.2 | 0.30 |
| ARID5B SRX10475138 | Hep G2 Liver | 524 / 11910 (4.4%) | 10898 / 119100 (9.2%) | −80.1 | −78.2 | 0.48 |
| EP300 SRX176883 | MCF-7 Breast | 149 / 11910 (1.3%) | 5255 / 119100 (4.4%) | −80.0 | −78.0 | 0.28 |
| FOXA1 SRX3923511 | MCF-7 Breast | 122 / 11910 (1.0%) | 4776 / 119100 (4.0%) | −80.0 | −78.0 | 0.26 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 689 / 11910 (5.8%) | 2894 / 119100 (2.4%) | −79.7 | −77.7 | 2.38 |
| Epitope tags DRX443510 | 293 Kidney | 920 / 11910 (7.7%) | 4450 / 119100 (3.7%) | −79.6 | −77.7 | 2.07 |
| FOXA1 SRX142908 | LNCAP Prostate | 169 / 11910 (1.4%) | 5581 / 119100 (4.7%) | −79.5 | −77.6 | 0.30 |
| FOXA1 SRX190282 | A549 Lung | 227 / 11910 (1.9%) | 6524 / 119100 (5.5%) | −79.4 | −77.4 | 0.35 |
| Epitope tags SRX5877913 | U2OS Bone | 1575 / 11910 (13.2%) | 23989 / 119100 (20.1%) | −79.3 | −77.4 | 0.66 |
| NANOG SRX2881137 | hESC H9 Pluripotent stem cell | 93 / 11910 (0.8%) | 4213 / 119100 (3.5%) | −79.3 | −77.3 | 0.22 |
| ESR1 SRX1012633 | MCF-7 Breast | 165 / 11910 (1.4%) | 5507 / 119100 (4.6%) | −79.2 | −77.3 | 0.30 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1222 / 11910 (10.3%) | 6650 / 119100 (5.6%) | −79.0 | −77.1 | 1.84 |
| ESR1 SRX4451214 | MCF-7 Breast | 274 / 11910 (2.3%) | 7242 / 119100 (6.1%) | −78.9 | −77.0 | 0.38 |
| ESR1 SRX1469951 | MCF-7 Breast | 166 / 11910 (1.4%) | 5505 / 119100 (4.6%) | −78.8 | −76.9 | 0.30 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 96 / 11910 (0.8%) | 4253 / 119100 (3.6%) | −78.7 | −76.8 | 0.23 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 598 / 11910 (5.0%) | 11838 / 119100 (9.9%) | −78.6 | −76.7 | 0.51 |
| GATA3 SRX5457550 | MCF-7 Breast | 359 / 11910 (3.0%) | 8504 / 119100 (7.1%) | −78.6 | −76.7 | 0.42 |
| CDK9 SRX7366780 | MCF-7 Breast | 127 / 11910 (1.1%) | 76 / 119100 (0.1%) | −78.6 | −76.6 | 16.71 |
| JUNB SRX4192882 | MCF 10A Breast | 261 / 11910 (2.2%) | 7031 / 119100 (5.9%) | −78.5 | −76.6 | 0.37 |
| FOXA1 SRX10306473 | T-47D Breast | 135 / 11910 (1.1%) | 4963 / 119100 (4.2%) | −78.5 | −76.6 | 0.27 |
| MEAF6 DRX300417 | 293 Kidney | 972 / 11910 (8.2%) | 4842 / 119100 (4.1%) | −78.5 | −76.6 | 2.01 |
| EP300 SRX1012643 | MCF-7 Breast | 118 / 11910 (1.0%) | 4658 / 119100 (3.9%) | −78.5 | −76.5 | 0.25 |
| ESR1 SRX5323872 | MCF-7 Breast | 313 / 11910 (2.6%) | 7816 / 119100 (6.6%) | −78.4 | −76.5 | 0.40 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 219 / 11910 (1.8%) | 6359 / 119100 (5.3%) | −78.2 | −76.3 | 0.34 |
| ESR1 SRX11120903 | MCF-7 Breast | 276 / 11910 (2.3%) | 7246 / 119100 (6.1%) | −78.1 | −76.2 | 0.38 |
| ESR1 SRX1995230 | MCF-7 Breast | 266 / 11910 (2.2%) | 7079 / 119100 (5.9%) | −77.8 | −75.9 | 0.38 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 230 / 11910 (1.9%) | 6518 / 119100 (5.5%) | −77.8 | −75.8 | 0.35 |
| JUNB SRX8488074 | SUM 229PE Breast | 423 / 11910 (3.6%) | 9377 / 119100 (7.9%) | −77.5 | −75.6 | 0.45 |
| EP300 SRX22550927 | CDS1 Bone | 478 / 11910 (4.0%) | 10150 / 119100 (8.5%) | −77.5 | −75.6 | 0.47 |
| FOXA1 SRX6878604 | LNCAP Prostate | 266 / 11910 (2.2%) | 7065 / 119100 (5.9%) | −77.4 | −75.5 | 0.38 |
| FOXA1 SRX5323830 | T-47D Breast | 196 / 11910 (1.6%) | 5959 / 119100 (5.0%) | −77.4 | −75.5 | 0.33 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 120 / 11910 (1.0%) | 64 / 119100 (0.1%) | −77.4 | −75.5 | 18.75 |
| SMARCA4 SRX5212357 | Mel270 Others | 458 / 11910 (3.8%) | 9862 / 119100 (8.3%) | −77.3 | −75.4 | 0.46 |
| FOXA1 SRX6860635 | T-47D Breast | 250 / 11910 (2.1%) | 6810 / 119100 (5.7%) | −77.2 | −75.3 | 0.37 |
| TEAD4 SRX190301 | hESC H1 Pluripotent stem cell | 236 / 11910 (2.0%) | 6590 / 119100 (5.5%) | −77.2 | −75.3 | 0.36 |
| Epitope tags SRX15939724 | RD Muscle | 286 / 11910 (2.4%) | 7364 / 119100 (6.2%) | −77.2 | −75.3 | 0.39 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 130 / 11910 (1.1%) | 4830 / 119100 (4.1%) | −77.2 | −75.3 | 0.27 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 96 / 11910 (0.8%) | 4208 / 119100 (3.5%) | −77.2 | −75.3 | 0.23 |
| SMARCA4 SRX5212366 | Mel270 Others | 430 / 11910 (3.6%) | 9463 / 119100 (7.9%) | −77.1 | −75.2 | 0.45 |
| FOXA1 SRX1961163 | T-47D Breast | 213 / 11910 (1.8%) | 6216 / 119100 (5.2%) | −77.0 | −75.1 | 0.34 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 602 / 11910 (5.1%) | 11811 / 119100 (9.9%) | −76.8 | −74.9 | 0.51 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 99 / 11910 (0.8%) | 4251 / 119100 (3.6%) | −76.8 | −74.9 | 0.23 |
| EP300 SRX1012644 | MCF-7 Breast | 149 / 11910 (1.3%) | 5150 / 119100 (4.3%) | −76.7 | −74.8 | 0.29 |
| FOXA1 SRX8406521 | Prostatic Neoplasms, Castration-Resistant Prostate | 125 / 11910 (1.0%) | 4722 / 119100 (4.0%) | −76.6 | −74.7 | 0.26 |
| KAT7 DRX234808 | 293 Kidney | 491 / 11910 (4.1%) | 1729 / 119100 (1.5%) | −76.5 | −74.6 | 2.84 |
| ESR1 SRX5323877 | MCF-7 Breast | 251 / 11910 (2.1%) | 6798 / 119100 (5.7%) | −76.5 | −74.6 | 0.37 |
| SOX2 SRX1047416 | hESC derived neural cells Pluripotent stem cell | 189 / 11910 (1.6%) | 5802 / 119100 (4.9%) | −76.2 | −74.3 | 0.33 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 354 / 11910 (3.0%) | 985 / 119100 (0.8%) | −76.1 | −74.2 | 3.59 |
| FOXA1 SRX497610 | VCaP Prostate | 283 / 11910 (2.4%) | 7271 / 119100 (6.1%) | −76.1 | −74.2 | 0.39 |
| ESR1 SRX1995229 | MCF-7 Breast | 317 / 11910 (2.7%) | 7782 / 119100 (6.5%) | −76.0 | −74.2 | 0.41 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1022 / 11910 (8.6%) | 5267 / 119100 (4.4%) | −76.0 | −74.1 | 1.94 |
| FOXA1 SRX10024494 | MCF-7 Breast | 59 / 11910 (0.5%) | 3436 / 119100 (2.9%) | −75.9 | −74.1 | 0.17 |
| ESR1 SRX2513518 | MCF-7 Breast | 162 / 11910 (1.4%) | 5340 / 119100 (4.5%) | −75.9 | −74.0 | 0.30 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 226 / 11910 (1.9%) | 6383 / 119100 (5.4%) | −75.8 | −73.9 | 0.35 |
| AR SRX9469987 | LAPC-4 Prostate | 157 / 11910 (1.3%) | 5251 / 119100 (4.4%) | −75.8 | −73.9 | 0.30 |
| EP300 SRX2194266 | SUM 159PT Breast | 544 / 11910 (4.6%) | 10980 / 119100 (9.2%) | −75.8 | −73.9 | 0.50 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1011 / 11910 (8.5%) | 5190 / 119100 (4.4%) | −75.7 | −73.8 | 1.95 |
| EOMES SRX035159 | hESC derived mesendodermal cells Pluripotent stem cell | 224 / 11910 (1.9%) | 6346 / 119100 (5.3%) | −75.7 | −73.8 | 0.35 |
| FOXA1 SRX497612 | VCaP Prostate | 313 / 11910 (2.6%) | 7706 / 119100 (6.5%) | −75.6 | −73.7 | 0.41 |
| FOXA1 SRX3923508 | MCF-7 Breast | 105 / 11910 (0.9%) | 4327 / 119100 (3.6%) | −75.6 | −73.7 | 0.24 |
| ESR1 SRX3110723 | MCF-7 Breast | 180 / 11910 (1.5%) | 5632 / 119100 (4.7%) | −75.6 | −73.7 | 0.32 |
| TEAD3 SRX2636153 | Hep G2 Liver | 757 / 11910 (6.4%) | 13785 / 119100 (11.6%) | −75.5 | −73.7 | 0.55 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 384 / 11910 (3.2%) | 8735 / 119100 (7.3%) | −75.4 | −73.5 | 0.44 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 553 / 11910 (4.6%) | 11083 / 119100 (9.3%) | −75.4 | −73.5 | 0.50 |
| FOXA1 SRX9604645 | LNCAP Prostate | 448 / 11910 (3.8%) | 9638 / 119100 (8.1%) | −75.3 | −73.4 | 0.46 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 327 / 11910 (2.7%) | 7898 / 119100 (6.6%) | −75.2 | −73.4 | 0.41 |
| FOXA1 SRX5323844 | MCF-7 Breast | 97 / 11910 (0.8%) | 4167 / 119100 (3.5%) | −75.2 | −73.3 | 0.23 |
| GATAD2A SRX2636507 | Hep G2 Liver | 360 / 11910 (3.0%) | 8378 / 119100 (7.0%) | −75.1 | −73.3 | 0.43 |
| ESR1 SRX2881001 | MCF-7 Breast | 182 / 11910 (1.5%) | 5649 / 119100 (4.7%) | −75.1 | −73.2 | 0.32 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 875 / 11910 (7.3%) | 15265 / 119100 (12.8%) | −75.0 | −73.2 | 0.57 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 964 / 11910 (8.1%) | 4874 / 119100 (4.1%) | −75.0 | −73.1 | 1.98 |
| FOXA1 SRX3931073 | MCF-7 Breast | 199 / 11910 (1.7%) | 5922 / 119100 (5.0%) | −75.0 | −73.1 | 0.34 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 215 / 11910 (1.8%) | 6174 / 119100 (5.2%) | −74.8 | −73.0 | 0.35 |
| ESR1 SRX5323874 | MCF-7 Breast | 198 / 11910 (1.7%) | 5898 / 119100 (5.0%) | −74.7 | −72.8 | 0.34 |
| NANOG SRX702040 | hESC HUES64 Pluripotent stem cell | 73 / 11910 (0.6%) | 3687 / 119100 (3.1%) | −74.7 | −72.8 | 0.20 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 555 / 11910 (4.7%) | 11079 / 119100 (9.3%) | −74.7 | −72.8 | 0.50 |
| VGLL1 SRX18013277 | FULVR Breast | 152 / 11910 (1.3%) | 5132 / 119100 (4.3%) | −74.7 | −72.8 | 0.30 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 281 / 11910 (2.4%) | 7191 / 119100 (6.0%) | −74.6 | −72.8 | 0.39 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 115 / 11910 (1.0%) | 4479 / 119100 (3.8%) | −74.6 | −72.8 | 0.26 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 213 / 11910 (1.8%) | 6130 / 119100 (5.1%) | −74.6 | −72.7 | 0.35 |
| FOXA1 SRX219284 | LNCAP Prostate | 440 / 11910 (3.7%) | 9489 / 119100 (8.0%) | −74.4 | −72.6 | 0.46 |
| ESR1 SRX5287697 | MCF-7 Breast | 119 / 11910 (1.0%) | 4544 / 119100 (3.8%) | −74.4 | −72.5 | 0.26 |
| ZEB1 SRX13298925 | MCF-7 Breast | 214 / 11910 (1.8%) | 6132 / 119100 (5.1%) | −74.2 | −72.3 | 0.35 |
| FOXA1 SRX497613 | VCaP Prostate | 247 / 11910 (2.1%) | 6649 / 119100 (5.6%) | −74.1 | −72.3 | 0.37 |
| AR SRX10365514 | MCF-7 Breast | 77 / 11910 (0.6%) | 3748 / 119100 (3.1%) | −74.1 | −72.2 | 0.21 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 893 / 11910 (7.5%) | 4393 / 119100 (3.7%) | −74.1 | −72.2 | 2.03 |
| FOXA1 SRX17794418 | 22Rv1 Prostate | 122 / 11910 (1.0%) | 4586 / 119100 (3.9%) | −74.1 | −72.2 | 0.27 |
| FOXA1 SRX3923525 | ZR-75-1 Breast | 120 / 11910 (1.0%) | 4552 / 119100 (3.8%) | −74.0 | −72.2 | 0.26 |
| FOXA1 SRX2642366 | VCaP Prostate | 325 / 11910 (2.7%) | 7821 / 119100 (6.6%) | −74.0 | −72.1 | 0.42 |
| NFIL3 SRX2630334 | Hep G2 Liver | 273 / 11910 (2.3%) | 7043 / 119100 (5.9%) | −73.9 | −72.1 | 0.39 |
| AR SRX15946405 | MDA-MB-453 Breast | 221 / 11910 (1.9%) | 6235 / 119100 (5.2%) | −73.9 | −72.0 | 0.35 |
| NR3C1 SRX19024866 | MCF-7 Breast | 120 / 11910 (1.0%) | 4541 / 119100 (3.8%) | −73.7 | −71.9 | 0.26 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1183 / 11910 (9.9%) | 6515 / 119100 (5.5%) | −73.7 | −71.9 | 1.82 |
| JUN SRX6582172 | Fibroblasts Others | 428 / 11910 (3.6%) | 9291 / 119100 (7.8%) | −73.7 | −71.8 | 0.46 |
| FOXA1 SRX15431000 | T-47D Breast | 273 / 11910 (2.3%) | 7033 / 119100 (5.9%) | −73.7 | −71.8 | 0.39 |
| ESR1 SRX5534831 | MCF-7 Breast | 257 / 11910 (2.2%) | 6786 / 119100 (5.7%) | −73.7 | −71.8 | 0.38 |
| ESR1 SRX2513519 | MCF-7 Breast | 180 / 11910 (1.5%) | 5565 / 119100 (4.7%) | −73.7 | −71.8 | 0.32 |
| CEBPB SRX7807101 | Unclassified Unclassified | 247 / 11910 (2.1%) | 6630 / 119100 (5.6%) | −73.6 | −71.8 | 0.37 |
| SOX5 SRX2636544 | Hep G2 Liver | 342 / 11910 (2.9%) | 8057 / 119100 (6.8%) | −73.6 | −71.8 | 0.42 |
| NR3C1 SRX8520802 | HCC1187 Breast | 244 / 11910 (2.0%) | 6584 / 119100 (5.5%) | −73.6 | −71.8 | 0.37 |
| AR SRX11149848 | MDA-MB-453 Breast | 222 / 11910 (1.9%) | 6236 / 119100 (5.2%) | −73.5 | −71.6 | 0.36 |
| WWTR1 SRX10119378 | MCF 10A Breast | 359 / 11910 (3.0%) | 8295 / 119100 (7.0%) | −73.4 | −71.6 | 0.43 |
| ARID1A SRX5089385 | MCF-7 Breast | 254 / 11910 (2.1%) | 6729 / 119100 (5.6%) | −73.4 | −71.6 | 0.38 |
| ESR1 SRX1012628 | MCF-7 Breast | 171 / 11910 (1.4%) | 5404 / 119100 (4.5%) | −73.3 | −71.5 | 0.32 |
| ING2 SRX286201 | RKO Digestive tract | 883 / 11910 (7.4%) | 4340 / 119100 (3.6%) | −73.3 | −71.5 | 2.03 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 610 / 11910 (5.1%) | 11754 / 119100 (9.9%) | −73.3 | −71.5 | 0.52 |
| FOXA1 SRX10024492 | MCF-7 Breast | 72 / 11910 (0.6%) | 3624 / 119100 (3.0%) | −73.3 | −71.5 | 0.20 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 341 / 11910 (2.9%) | 8027 / 119100 (6.7%) | −73.2 | −71.4 | 0.42 |
| FOXA1 SRX7570769 | Bronchial epithelial cells Lung | 76 / 11910 (0.6%) | 3700 / 119100 (3.1%) | −73.1 | −71.3 | 0.21 |
| FOXA1 SRX497611 | VCaP Prostate | 262 / 11910 (2.2%) | 6842 / 119100 (5.7%) | −73.1 | −71.3 | 0.38 |
| FOXA1 SRX3923510 | MCF-7 Breast | 133 / 11910 (1.1%) | 4752 / 119100 (4.0%) | −73.1 | −71.2 | 0.28 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 434 / 11910 (3.6%) | 9343 / 119100 (7.8%) | −73.0 | −71.2 | 0.46 |
| EP300 SRX2671806 | iPS cells Pluripotent stem cell | 72 / 11910 (0.6%) | 3618 / 119100 (3.0%) | −73.0 | −71.1 | 0.20 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1208 / 11910 (10.1%) | 6726 / 119100 (5.6%) | −72.9 | −71.1 | 1.80 |
| ARID1A SRX5089388 | MCF-7 Breast | 178 / 11910 (1.5%) | 5505 / 119100 (4.6%) | −72.9 | −71.1 | 0.32 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 221 / 11910 (1.9%) | 6196 / 119100 (5.2%) | −72.8 | −71.0 | 0.36 |
| NCOA3 SRX4663589 | MCF-7 Breast | 101 / 11910 (0.8%) | 4167 / 119100 (3.5%) | −72.8 | −71.0 | 0.24 |
| RAD21 SRX3482875 | hESC HUES64 Pluripotent stem cell | 512 / 11910 (4.3%) | 10410 / 119100 (8.7%) | −72.7 | −70.9 | 0.49 |
Showing first 500 of 15504 rows.